Twan Lammers
Active 2005–2026
- 166
- Papers
- 27,854
- Citations
- 89
- h-index
- 161
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine26.6%
- Materials Science21.9%
- Engineering19%
- Biochemistry, Genetics and Molecular Biology18.5%
- Immunology and Microbiology5.7%
- Pharmacology, Toxicology and Pharmaceutics3%
- Other5.3%
Topics
- Nanoparticle-Based Drug Delivery10.2%
- Nanoplatforms for cancer theranostics9.1%
- RNA Interference and Gene Delivery5.2%
- Advanced biosensing and bioanalysis techniques3.2%
- Immunotherapy and Immune Responses2.2%
- Advanced Drug Delivery Systems1.9%
- Other68.2%
Coauthors
- Fabian Kießling88
- Gert Storm48
- Wim E. Hennink30
- Yang Shi27
- Felix Gremse18
- Josef Ehling17
- Frank Tacke16
- Christian Trautwein14
- Diana Möckel14
- Alexandros Marios Sofias12
- Josbert M. Metselaar12
- Matthias Bartneck12
- Benjamin Theek11
- Ralf Weiskirchen11
- Anne Rix10
- Anshuman Dasgupta10
- Cristianne J.F. Rijcken10
- Karel Ulbrich9
- Natascha Drude9
- Peter Boor9
- Robert Pola9
- Maike Baues8
- Michal Pechar8
- Roger M. Pallares8
All papers
- Smart cancer nanomedicine
Authors: Roy van der Meel, Einar Sulheim, Yang Shi, Fabian Kießling, Willem J. M. Mulder, Twan Lammers - Nature Nanotechnology 2019 cited by 1,196
- The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy
Authors: Yang Shi, Roy van der Meel, Xiaoyuan Chen, Twan Lammers - Theranostics 2020 cited by 830
- Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine
Authors: Omer Adir, Maria Poley, Gal Chen, Sahar Froim, Nitzan Krinsky, Jeny Shklover, Janna Shainsky‐Roitman, Twan Lammers, Avi Schroeder - Advanced Materials 2019 cited by 475
- Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Authors: Seyed Mohammadali Dadfar, Karolin Roemhild, Natascha Drude, Saskia von Stillfried, Ruth Knüchel, Fabian Kießling, Twan Lammers - Advanced Drug Delivery Reviews 2019 cited by 1,139
- Cancer nanomedicine
Authors: Sangeeta N. Bhatia, Xiaoyuan Chen, Marina A. Dobrovolskaia, Twan Lammers - Nature reviews. Cancer 2022 cited by 381
- Tumor targeting via EPR: Strategies to enhance patient responses
Authors: Susanne K. Golombek, Jan‐Niklas May, Benjamin Theek, Lia Appold, Natascha Drude, Fabian Kießling, Twan Lammers - Advanced Drug Delivery Reviews 2018 cited by 1,223
- Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting
Authors: Rahul Rimal, Prachi Desai, Rasika Daware, Aisa Hosseinnejad, Jai Prakash, Twan Lammers, Smriti Singh - Advanced Drug Delivery Reviews 2022 cited by 179
- Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Authors: Jennifer I. Hare, Twan Lammers, Marianne Ashford, Sanyogitta Puri, Gert Storm, Simon T. Barry - Advanced Drug Delivery Reviews 2016 cited by 1,156
- Combining Nanomedicine and Immunotherapy
Authors: Yang Shi, Twan Lammers - Accounts of Chemical Research 2019 cited by 456
- Iron metabolism: pathophysiology and pharmacology
Authors: Karolin Roemhild, Finn von Maltzahn, Ralf Weiskirchen, Ruth Knüchel, Saskia von Stillfried, Twan Lammers - Trends in Pharmacological Sciences 2021 cited by 284
- Challenges in nanomedicine clinical translation
Authors: Josbert M. Metselaar, Twan Lammers - Drug Delivery and Translational Research 2020 cited by 347
- Sublethal necroptosis signaling promotes inflammation and liver cancer
Authors: Mihael Vucur, Ahmed Ghallab, Anne T. Schneider, Arlind Adili, Mingbo Cheng, M. Castoldi, Michael T. Singer, Veronika Büttner, Leonie Keysberg, Lena Küsgens, Marlene Kohlhepp, Boris Görg, Suchira Gallage, Jose Efren Barragan Avila, Kristian Unger, Claus Kordes, Anne‐Laure Leblond, Wiebke Albrecht, Sven H. Loosen, Carolin Lohr, Markus S. Jördens, Anne Babler, Sikander Hayat, David Schumacher, Maria Teresa Koenen, Olivier Govaere, Mark V. Boekschoten, Simone Jörs, Carlos Villacorta-Martín, Vincenzo Mazzaferro, Josep M. Llovet, Ralf Weiskirchen, Jakob Nikolas Kather, Patrick Starlinger, Michael Trauner, Mark Luedde, Lara R. Heij, Ulf P. Neumann, Verena Keitel, Johannes G. Bode, Rebekka K. Schneider, Frank Tacke, Bodo Levkau, Twan Lammers, Georg Fluegen, Theodore Alexandrov, Amy Collins, Glyn Nelson, Fiona Oakley, Derek A. Mann, Christoph Roderburg, Thomas Longerich, Achim Weber, Augusto Villanueva, André L. Samson, James M. Murphy, Rafael Kramann, Fabian Geisler, Ivan G. Costa, Jan G. Hengstler, Mathias Heikenwälder, Tom Luedde - Immunity 2023 cited by 133
- Nanomedicine Tumor Targeting
Authors: Twan Lammers - Advanced Materials 2024 cited by 226
- A translational framework to DELIVER nanomedicines to the clinic
Authors: Paul Joyce, Christine Allen, Marı́a José Alonso, Marianne Ashford, Michelle S. Bradbury, Matthieu Germain, Maria Kavallaris, Róbert Langer, Twan Lammers, Maria Teresa Peracchia, Amirali Popat, Clive A. Prestidge, Cristianne J.F. Rijcken, Bruno Sarmento, Ruth Schmid, Avi Schroeder, Santhni Subramaniam, Chelsea R. Thorn, Kathryn A. Whitehead, Chun‐Xia Zhao, Hélder A. Santos - Nature Nanotechnology 2024 cited by 219
- PLGA-Based Nanoparticles in Cancer Treatment
Authors: Sima Rezvantalab, Natascha Drude, Mostafa Keshavarz Moraveji, Nihan Güvener, Emily Kate Koons, Yang Shi, Twan Lammers, Fabian Kießling - Frontiers in Pharmacology 2018 cited by 588
- Motion model ultrasound localization microscopy for preclinical and clinical multiparametric tumor characterization
Authors: Tatjana Opacic, Stefanie Dencks, Benjamin Theek, Marion Piepenbrock, Dimitri Ackermann, Anne Rix, Twan Lammers, Elmar Stickeler, Stefan Delorme, Georg Schmitz, Fabian Kießling - Nature Communications 2018 cited by 286
- From structural design to delivery: mRNA therapeutics for cancer immunotherapy
Authors: Feng Zhou, Lujia Huang, Shiqin Li, Wenfang Yang, Fangmin Chen, Zhixiong Cai, Xiaolong Liu, Wujun Xu, Vesa‐Pekka Lehto, Ulrich Lächelt, Rongqin Huang, Yang Shi, Twan Lammers, Wei Tao, Zhi Ping Xu, Ernst Wagner, Zhiai Xu, Haijun Yu, Zhiai Xu, Haijun Yu - Exploration 2023 cited by 105
- Metallodrugs in cancer nanomedicine
Authors: Quim Peña, Alec Wang, Orysia Zaremba, Yang Shi, Hans W. Scheeren, Josbert M. Metselaar, Fabian Kießling, Roger M. Pallares, Stefan Wuttke, Twan Lammers - Chemical Society Reviews 2022 cited by 235
- Toxicity of metal–organic framework nanoparticles: from essential analyses to potential applications
Authors: Romy Ettlinger, Ulrich Lächelt, Ruxandra Gref, Patricia Horcajada, Twan Lammers, Christian Serre, Patrick Couvreur, Russell E. Morris, Stefan Wuttke - Chemical Society Reviews 2022 cited by 391
- Targeting iron metabolism in drug discovery and delivery
Authors: Bart J. Crielaard, Twan Lammers, Stefano Rivella - Nature Reviews Drug Discovery 2017 cited by 359
- Drug Targeting to Tumors: Principles, Pitfalls and (Pre-) Clinical Progress
Authors: Twan Lammers, Fabian Kießling, Wim E. Hennink, Gert Storm - Journal of Controlled Release 2011 cited by 1,288
- 3D‐Bioprinted Mini‐Brain: A Glioblastoma Model to Study Cellular Interactions and Therapeutics
Authors: Marcel Alexander Heinrich, Ruchi Bansal, Twan Lammers, Yu Shrike Zhang, Raymond M. Schiffelers, Jai Prakash - Advanced Materials 2019 cited by 307
- Clinically established biodegradable long acting injectables: An industry perspective
Authors: Christian Isalomboto Nkanga, Andreas Fisch, Mazda Rad‐Malekshahi, Marieta Duvnjak Romić, Birgit Kittel, Thomas Ullrich, Jing Wang, Rui W. M. Krause, Sabine Adler, Twan Lammers, Wim E. Hennink, Farshad Ramazani - Advanced Drug Delivery Reviews 2020 cited by 151
- Nanoparticles for Cancer Diagnosis, Radionuclide Therapy and Theranostics
Authors: Jordi Llop, Twan Lammers - ACS Nano 2021 cited by 104
